Blood Screening Market
According to Intent Market Research, the Blood Screening Market is expected to grow from USD 2.3 billion in 2023-e at a CAGR of 6.7% to touch USD 3.6 billion by 2030. The blood screening market is dominated by key players such as Roche, Abbott, bioMérieux, Bio-Rad Laboratories, Siemens Healthineers, Danaher, and Thermo Fisher Scientific.